Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Shigeru SHIRAKAWA"'
Autor:
Youichiro Ohno, Masaharu Kasai, Masayuki Sano, Tohru Kobayashi, Yoshihiro Matsuno, Kensei Tobinai, Toshiaki Sai, Naoki Ishizuka, Tomomitsu Hotta, Chikara Mikuni, Yasufumi Masaki, Michinori Ogura, Masao Tomonaga, Shigeru Shirakawa, Takenaka T, Hironobu Toki, Tomohiro Kinoshita, Masanori Shimoyama, Tomoko Ohtsu
Publikováno v:
International Journal of Hematology. 80:341-350
The effect of enhancing the dose intensity (DI) of the key drugs in multidrug combination chemotherapy for malignant lymphoma is uncertain. We investigated the survival benefit of dose-intensified multidrug combination chemotherapy for intermediate-
Autor:
Yasusada Miura, Atsushi Horiuchi, Masao Tomonaga, Shigeru Shirakawa, Ryuzo Ohno, Akira Shibata, Kensuke Usuki, Syozo Irino, Kiyoshi Takatsuki, Ikurou Kimura, Tsukasa Abe, Atsushi Kuramoto, Minoru Ohkuma, Tamotsu Matsuda, Yasuo Ikeda, Nakamura Toru, Tamotsu Miyazaki, Fumimaro Takaku, Takeo Nomura, Toru Masaoka, Hideaki Mizoguchi, Akira B. Miura, Tadami Nagao, Akio Urabe, Yoshiyuki Niho, Haruto Uchino, Yutaka Yoshida, Yousirou Niitsu, Nobuyuki Hamajima, Hidehiko Saitou
Publikováno v:
British Journal of Haematology. 116:103-112
Summary. To investigate the efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in patients with acute myelogenous leukaemia, a multicentre randomized study was performed. From October 1993 to September 1996, 270 patients with newly
Autor:
Hiroshi Konishi, Toshiaki Sai, Hironobu Toki, Yoshinori Shimamoto, Kinuko Tajima, Satoshi Inaba, Haruhiko Fukuda, Koichi Araki, Akira B. Miura, Masanori Shimoyama, Yoh-ichiro Ohno, Michito Ichimaru, Chikara Mikuni, Masami Hirano, Takenaka T, Shigeru Shirakawa, Shuichi Hanada, Miyuki Niimi
Publikováno v:
Japanese Journal of Clinical Oncology. 29:485-489
Group (JCOG). Results: Eighty-one previously untreated patients were enrolled in the study. For 69 eligible patients, the response rate was 50.7% [95% confidence interval (CI) 38.4-63.0%]. The median survival time was 38.5 (95% CI 32.0-44.4) months.
Autor:
Kinuko Tajima, Masanori Shimoyama, Tohru Kobayashi, Toshiaki Sai, Atsushi Oyama, Tomomitsu Hotta, Koichi Araki, Shiro Fukuhara, Hironobu Toki, Miyuki Niimi, Shigeru Shirakawa, Naohito Yamaguchi, Makoto Matsumoto, Kijo Deura, Isao Aoki, Haruhiko Fukuda, Mitsuo Kozuru, Masami Nagai, Kensei Tobinai, Tatsuo Abe, Chikara Mikuni, Susumu Konda
Publikováno v:
Japanese Journal of Clinical Oncology. 29:340-348
Background Patients with acute lymphocytic leukemia (ALL) and those with lymphoblastic lymphoma (LBL) have overlapping clinical and immunophenotypic features and they have been treated with the same or very similar chemotherapy regimens. The goal of
Autor:
Tohru Kobayashi, Kazunori Ohnishi, Yutaka Ariyoshi, Kensei Tobinai, Kunihiko Takeyama, Tomomitsu Hotta, Yasuo Ohashi, Hidehiko Saito, Michinori Ogura, Shigeru Shirakawa, Ryuzo Ohno
Publikováno v:
Japanese Journal of Clinical Oncology. 26:455-460
Irinotecan hydrochloride (CPT-11) is a new derivative of camptothecin which inhibits topoisomerase I. Phase II studies have demonstrated that CPT-11 is active against a broad spectrum of neoplasms including intractable non-Hodgkin's lymphoma. An earl
Autor:
Naoyuki Katayama, R. Itoh, Nobuyuki Minami, Stewart D. Lyman, Kenkichi Kita, Hiroshi Miwa, Nadim Mahmud, Kohshi Ohishi, Shigeru Shirakawa, Hiroshi Shiku
Publikováno v:
Blood. 87:1718-1727
Although hematopoietic growth factors have been extensively studied as to their roles in recruitment of hematopoietic progenitors from quiescence state to cell division state, little is known of their effects on cell-cycling of progenitors that have
Autor:
Hiroshi Miwa, Kouji Oka, Nadim Mahmud, Shigeru Shirakawa, Toshiyuki Ohno, Hiroshi Shiku, Motoko Yamaguchi, Kenkichi Kita
Publikováno v:
Scopus-Elsevier
The t(11;14) (q13;q32) translocation and its molecular counterpart Bcl-1 rearrangement are consistent features of mantle cell lymphoma (MCL). This translocation activates the PRAD1/cyclin D1 gene that is considered to be the Bcl-1 oncogene. PRAD1/cyc
Autor:
Kenkichi Kita, Toshiyuki Ohno, Hiroshi Miwa, Kazuhiro Nishii, Shigeru Shirakawa, Kouji Oka, Manabu Fukumoto, Motoko Yamaguchi
Publikováno v:
Cancer. 76:2351-2356
Background Lethal midline granuloma is now considered to be a malignant lymphoma derived from peripheral T cells or from natural killer cells. The therapeutic outcome of nasal T-cell lymphoma (NL) treated by conventional chemotherapy for non-Hodgkin'
Autor:
Mikio Takagi, S. Nagaya, Kouzou Minamikawa, S Yano, K Mukai, Hideo Wada, T. Nakase, Deguchi K, Koji Suzuki, H Kihira, Yoshihiro Wakita, Shigeru Shirakawa
Publikováno v:
Blood Coagulation & Fibrinolysis. 5:713-717
Plasma levels of the vascular endothelial cell markers, thrombomodulin (TM), plasminogen activator inhibitor-1 (PAI-1), tissue type plasminogen activator (t-PA), and von Willebrand factor (vWF) were measured in 55 patients on maintenance haemodialysi
Autor:
Tatsuki Matsuo, Minoru Yoshida, Akira Hiraoka, Toshiteru Oshima, Kazutaka Kuriyama, Masao Tomonaga, Koichi Adachi, Keisuke Minato, Nobuhiko Emi, Hiroshi Miwa, Isao Takahashi, Kazuo Tsubaki, Tohru Kobayashi, Hirokazu Murakami, Nobuhiko Tominaga, Shinpei Furusawa, Norio Asou, Mitsune Tanimoto, Kuniyuki Imai, Ryuzo Ohno, Saburoh Minami, Shigeru Shirakawa
Publikováno v:
British Journal of Haematology. 86:767-773
The findings of morphologically dysplastic features in haemopoietic cells in de novo acute myeloid leukaemia (AML) has been named AML with trilineage myelodysplasia (AML/TMDS). We analysed the clinical data, karyotypes, and treatment outcomes of 230